• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The FDA, regulation, and the risk of stroke.

作者信息

Fleming G A

出版信息

N Engl J Med. 2000 Dec 21;343(25):1886-7. doi: 10.1056/NEJM200012213432510.

DOI:10.1056/NEJM200012213432510
PMID:11117982
Abstract
摘要

相似文献

1
The FDA, regulation, and the risk of stroke.美国食品药品监督管理局、监管与中风风险
N Engl J Med. 2000 Dec 21;343(25):1886-7. doi: 10.1056/NEJM200012213432510.
2
Phenylpropanolamine and hemorrhagic stroke.
N Engl J Med. 2001 Apr 5;344(14):1094; author reply 1095.
3
Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.与含有麻黄生物碱的膳食补充剂相关的不良心血管和中枢神经系统事件。
N Engl J Med. 2000 Dec 21;343(25):1833-8. doi: 10.1056/NEJM200012213432502.
4
Phenylpropanolamine and hemorrhagic stroke in the Hemorrhagic Stroke Project: a reappraisal in the context of science, the Food and Drug Administration, and the law.
Ann Epidemiol. 2006 Jan;16(1):49-52. doi: 10.1016/j.annepidem.2005.01.012. Epub 2005 Oct 10.
5
FDA issues public health advisory on phenylpropanolamine in drug products.
FDA Consum. 2001 Jan-Feb;35(1):9.
6
Phenylpropanolamine and stroke: the study, the FDA ruling, the implications.
Cleve Clin J Med. 2001 Mar;68(3):208-9, 213-9, 223. doi: 10.3949/ccjm.68.3.208.
7
Phenylpropanolamine and hemorrhagic stroke.
N Engl J Med. 2001 Apr 5;344(14):1094-5. doi: 10.1056/NEJM200104053441411.
8
[Stroke and phenylpropanolamine: what risk factors and what recommendations in request?].
Dakar Med. 2007;52(1):56-7.
9
Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin America.
Drug Saf. 2002;25(10):689-93. doi: 10.2165/00002018-200225100-00001.
10
Regarding "Phenylpropanolamine and hemorrhagic stroke in the hemorrhagic stroke project": mercenary epidemiology--data reanalysis and reinterpretation for sponsors with financial interest in the outcome.
Ann Epidemiol. 2006 Jul;16(7):583-5; author reply 586. doi: 10.1016/j.annepidem.2006.04.004.

引用本文的文献

1
Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association.耐药性高血压：检测、评估与管理：美国心脏协会科学声明。
Hypertension. 2018 Nov;72(5):e53-e90. doi: 10.1161/HYP.0000000000000084.
2
Comprehensive review of cardiovascular toxicity of drugs and related agents.药物和相关制剂的心血管毒性的综合评价
Med Res Rev. 2018 Jul;38(4):1332-1403. doi: 10.1002/med.21476. Epub 2018 Jan 5.
3
Pharmacotherapy of urinary incontinence.尿失禁的药物治疗
Int Urogynecol J Pelvic Floor Dysfunct. 2009 Apr;20(4):475-82. doi: 10.1007/s00192-008-0761-1. Epub 2008 Nov 12.
4
Rimonabant: the role of endocannabinoid type 1 receptor antagonism in modulating the weight and lipid profile of obese patients.利莫那班：1型内源性大麻素受体拮抗作用在调节肥胖患者体重和脂质谱方面的作用
Curr Atheroscler Rep. 2007 Nov;9(5):359-66. doi: 10.1007/s11883-007-0046-z.
5
Safety of drug therapies used for weight loss and treatment of obesity.用于减肥和肥胖症治疗的药物疗法的安全性。
Drug Saf. 2006;29(4):277-302. doi: 10.2165/00002018-200629040-00001.
6
Pharmacotherapy for stress urinary incontinence : present and future options.压力性尿失禁的药物治疗：现状与未来选择
Drugs. 2004;64(14):1503-16. doi: 10.2165/00003495-200464140-00001.
7
Regulatory decisions in a globalised world: the domino effect of phenylpropanolamine withdrawal in Latin America.
Drug Saf. 2002;25(10):689-93. doi: 10.2165/00002018-200225100-00001.